Patent Board

The Patent Board was a premier intellectual property analytics firm that specialized in the quantitative evaluation and benchmarking of corporate patent portfolios. The company was widely recognized for its "Patent Scorecards," which were published in the Wall Street Journal and provided industry-standard rankings of innovation strength. In the life sciences sector, its "Biotechnology Patent Scorecard" was a vital tool for analysts to measure the R&D productivity and competitive positioning of biotech and pharmaceutical companies. The firm utilized proprietary metrics such as Science Strength and Technology Strength to assess the quality of a company's intellectual property and its impact on future technology. The assets of the company were acquired by LexisNexis in 2012, where its methodologies were integrated into the LexisNexis IP analytics suite.